Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Hypertension pharmacogenomics: current status and future directions.

Johnson JA, Turner ST.

Curr Opin Mol Ther. 2005 Jun;7(3):218-25. Review.

PMID:
15977418
2.

Pharmacogenetics of antihypertensive drug responses.

Schwartz GL, Turner ST.

Am J Pharmacogenomics. 2004;4(3):151-60. Review.

PMID:
15174896
3.

Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges.

Johnson JA, Lima JJ.

Pharmacogenetics. 2003 Sep;13(9):525-34. Review.

PMID:
12972951
4.

Pharmacogenetics of antihypertensive treatment.

Arnett DK, Claas SA, Glasser SP.

Vascul Pharmacol. 2006 Feb;44(2):107-18. Epub 2005 Dec 13. Review.

PMID:
16356784
5.

Pharmacogenomics of essential hypertension: are we going the right way?

Filigheddu F, Troffa C, Glorioso N.

Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):7-15. Review.

PMID:
16529546
6.

Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives--the adducin paradigm.

Manunta P, Bianchi G.

J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S30-5. Review.

7.

Cardiovascular pharmacogenomics.

Johnson JA, Cavallari LH.

Exp Physiol. 2005 May;90(3):283-9. Epub 2005 Mar 18. Review.

8.

Pharmacogenetics of hypertension treatment: a structured review.

Koopmans RP, Insel PA, Michel MC.

Pharmacogenetics. 2003 Dec;13(12):705-13. Review.

PMID:
14646689
9.

Pharmacogenomics of hypertension.

Cadman PE, O'Connor DT.

Curr Opin Nephrol Hypertens. 2003 Jan;12(1):61-70. Review.

PMID:
12496668
10.

Drug target pharmacogenomics: an overview.

Johnson JA.

Am J Pharmacogenomics. 2001;1(4):271-81. Review.

PMID:
12083959
11.

Pharmacogenomics: a new approach to individual therapy of hypertension?

Ferrari P.

Curr Opin Nephrol Hypertens. 1998 Mar;7(2):217-22. Review.

PMID:
9529626
12.

The future of antihypertensive treatment.

Israili ZH, Hernández-Hernández R, Valasco M.

Am J Ther. 2007 Mar-Apr;14(2):121-34. Review.

PMID:
17414579
13.

Antihypertensive pharmacogenetics: getting the right drug into the right patient.

Turner ST, Schwartz GL, Chapman AB, Hall WD, Boerwinkle E.

J Hypertens. 2001 Jan;19(1):1-11. Review.

PMID:
11204288
14.

Pharmacogenetics of beta1-adrenergic receptors in heart failure and hypertension.

Mialet-Perez J, Liggett SB.

Arch Mal Coeur Vaiss. 2006 Jun;99(6):616-20. Review.

PMID:
16878723
15.

Genetic determinants of blood pressure regulation.

Marteau JB, Zaiou M, Siest G, Visvikis-Siest S.

J Hypertens. 2005 Dec;23(12):2127-43. Review.

PMID:
16269952
16.

Pharmacogenetics: from discovery to patient care.

Shin J, Kayser SR, Langaee TY.

Am J Health Syst Pharm. 2009 Apr 1;66(7):625-37. doi: 10.2146/ajhp080170. Review.

PMID:
19299369
17.

Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.

Mango R, Vecchione L, Raso B, Borgiani P, Brunetti E, Mehta JL, Lauro R, Romeo F, Novelli G.

Expert Opin Pharmacother. 2005 Dec;6(15):2565-76. Review.

PMID:
16316297
18.

Evolution of pharmacogenomics.

Somogy A.

Proc West Pharmacol Soc. 2008;51:1-4. Review.

PMID:
19544663
19.

Advancing management of hypertension through pharmacogenomics.

Johnson JA.

Ann Med. 2012 Jun;44 Suppl 1:S17-22. doi: 10.3109/07853890.2011.653399. Review.

20.

Pharmacogenomics and drug response.

Müller M.

Int J Clin Pharmacol Ther. 2003 Jun;41(6):231-40. Review.

PMID:
12816175

Supplemental Content

Support Center